(HealthDay News) — For older adults with type 2 diabetes, glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with nonarteritic anterior ischemic optic neuropathy (NAION), according ...

New research has revealed factors associated with an increased risk of COVID-19-related death and hospitalization among patients with cancer.

(HealthDay News) — Canagliflozin is associated with a clinically meaningful reduction in hemoglobin A1c (HbA1c) for children and adolescents with type 2 diabetes mellitus (T2DM), according to a study ...

No significant increases seen in rate of hospital contacts for any of 29 adverse events in 28-day risk period after vaccination.

(HealthDay News) — Cardiovascular risk factor and disease mortality varies significantly among Asian Indian, Chinese, and Filipino Americans, with Filipino Americans having the highest mortality ...

Pemivibart was well tolerated and prophylactic against COVID-19 infection among adult patients with significant immunocompromising conditions.

In solid organ transplant recipients (SOTRs) with advanced cancer treated with immune checkpoint inhibitors (ICIs), cancer outcomes and transplant rejection risk vary by cancer type, investigators ...

A phase 2 trial tested the efficacy and safety of potravitug, an investigational monoclonal antibody, in kidney transplant recipients with BK polyomavirus DNAemia.

The FDA has approved Empaveli for the treatment of adult and pediatric patients aged 12 years and older with C3G or primary ...

Using artificial intelligence tools in urology requires an open mind but with appropriate cautions according to clinicians ...

Single-port robotic surgery sparked interest and debate at the American Urological Association annual meeting (AUA 2025).

Medical knowledge is not enough to guard surgeons from premature death, data suggest. Surgeons need further support to protect their own health.